Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prediction model for hepatocellular carcinoma risk in treatment-naive chronic hepatitis B patients receiving entecavir/tenofovir
Jung Hwan Yu, Young Ju Suh, Young‐Joo Jin, et al.
European Journal of Gastroenterology & Hepatology (2019) Vol. 31, Iss. 7, pp. 865-872
Closed Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Hepatitis B Virus-Associated Hepatocellular Carcinoma
Giacomo Emanuele Maria Rizzo, Giuseppe Cabibbo, Antonio Craxı̀
Viruses (2022) Vol. 14, Iss. 5, pp. 986-986
Open Access | Times Cited: 116
Hepatocellular carcinoma surveillance — utilization, barriers and the impact of changing aetiology
Daniel Q. Huang, Amit G. Singal, Fasiha Kanwal, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 12, pp. 797-809
Closed Access | Times Cited: 90
Risk stratification and early detection biomarkers for precision HCC screening
Yi‐Te Lee, Naoto Fujiwara, Ju Dong Yang, et al.
Hepatology (2022), pp. n/a-n/a
Open Access | Times Cited: 64
Development of hepatocellular carcinoma in treated and untreated patients with chronic hepatitis B virus infection
Chih–Lin Lin, Jia‐Horng Kao
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 3, pp. 605-622
Open Access | Times Cited: 40
Validation Study of Scores Predicting Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Treated With Nucleos(t)ide Analogues
Jun Inoue, Shinichiro Minami, Kazumichi Abe, et al.
Journal of Viral Hepatitis (2025) Vol. 32, Iss. 4
Open Access | Times Cited: 1
Hepatocellular Carcinoma Prediction Models in Chronic Hepatitis B: A Systematic Review of 14 Models and External Validation
Shanshan Wu, Na Zeng, Feng Sun, et al.
Clinical Gastroenterology and Hepatology (2021) Vol. 19, Iss. 12, pp. 2499-2513
Open Access | Times Cited: 42
Clinical utility of hepatocellular carcinoma risk scores in chronic hepatitis B
Theodoros Voulgaris, Μargarita Papatheodoridi, Pietro Lampertico, et al.
Liver International (2019) Vol. 40, Iss. 3, pp. 484-495
Open Access | Times Cited: 53
Comparative performance of risk prediction models for hepatitis B-related hepatocellular carcinoma in the United States
Hyun‐seok Kim, Xian Yu, Jennifer R. Kramer, et al.
Journal of Hepatology (2021) Vol. 76, Iss. 2, pp. 294-301
Open Access | Times Cited: 35
A Liver Stiffness–Based Etiology-Independent Machine Learning Algorithm to Predict Hepatocellular Carcinoma
Huapeng Lin, Guanlin Li, Adèle Delamarre, et al.
Clinical Gastroenterology and Hepatology (2023) Vol. 22, Iss. 3, pp. 602-610.e7
Closed Access | Times Cited: 16
The best predictive model for hepatocellular carcinoma in patients with chronic hepatitis B infection
Jung Hwan Yu, Soon Gu Cho, Young‐Joo Jin, et al.
Clinical and Molecular Hepatology (2021) Vol. 28, Iss. 3, pp. 351-361
Open Access | Times Cited: 30
Comparison of tenofovir versus entecavir for preventing hepatocellular carcinoma in chronic hepatitis B patients: an umbrella review and meta-analysis
Shijia Liu, Xiao Zhang, Lun‐Jie Yan, et al.
Journal of Cancer Research and Clinical Oncology (2025) Vol. 151, Iss. 2
Open Access
A Review of Risk Prediction Model for Hepatocellular Carcinoma in Chronic Hepatitis B
Jiwon Yang, Mark Muthiah, Won‐Mook Choi
Current Hepatology Reports (2025) Vol. 24, Iss. 1
Closed Access
Stratification of Hepatocellular Carcinoma Risk Following HCV Eradication or HBV Control
Pierre Nahon, Erwan Vo Quang, Nathalie Ganne‐Carrié
Journal of Clinical Medicine (2021) Vol. 10, Iss. 2, pp. 353-353
Open Access | Times Cited: 27
A machine learning model for predicting hepatocellular carcinoma risk in patients with chronic hepatitis B
Hye Won Lee, Hwiyoung Kim, T. K. Park, et al.
Liver International (2023) Vol. 43, Iss. 8, pp. 1813-1821
Closed Access | Times Cited: 10
Long-term Virological and Clinical Evaluation of Chronic Hepatitis B Patients Under Nucleos(t)ide Analogues Therapy
Maria Stella Franzè, Carlo Saitta, Daniele Lombardo, et al.
Clinics and Research in Hepatology and Gastroenterology (2025), pp. 102566-102566
Closed Access
Behaviour‐Based Predictive Scores of Hepatocellular Carcinoma in People With Chronic Hepatitis B (ANRS CO22 HEPATHER)
Clémence Ramier, Camélia Protopopescu, Vincent Di Beo, et al.
Liver International (2025) Vol. 45, Iss. 4
Open Access
Serum hepatitis B core-related antigen predicts hepatocellular carcinoma in hepatitis B e antigen-negative patients
Lilian Yan Liang, Vincent Wai–Sun Wong, Hidenori Toyoda, et al.
Journal of Gastroenterology (2020) Vol. 55, Iss. 9, pp. 899-908
Closed Access | Times Cited: 27
Risk Scores for Hepatocellular Carcinoma in Chronic Hepatitis B: A Promise for Precision Medicine
George Papatheodoridis, Theodoros Voulgaris, Μargarita Papatheodoridi, et al.
Hepatology (2020) Vol. 72, Iss. 6, pp. 2197-2205
Closed Access | Times Cited: 25
Prognostic significance of dynamic changes in liver stiffness measurement in patients with chronic hepatitis B and compensated advanced chronic liver disease
Hongsheng Yu, Yinan Huang, Mingkai Li, et al.
Journal of Gastroenterology and Hepatology (2024) Vol. 39, Iss. 10, pp. 2169-2181
Closed Access | Times Cited: 3
Magnitude of and prediction for risk of hepatocellular carcinoma in patients with chronic hepatitis B taking entecavir or tenofovir therapy: A systematic review
Cheng‐Hao Tseng, Chao‐Ming Tseng, Jia‐Ling Wu, et al.
Journal of Gastroenterology and Hepatology (2020) Vol. 35, Iss. 10, pp. 1684-1693
Closed Access | Times Cited: 21
Prevention of hepatitis B virus-related hepatocellular carcinoma
Chih–Lin Lin, Jia‐Horng Kao
Hepatoma Research (2021) Vol. 2021
Open Access | Times Cited: 19
Surveillance for hepatocellular carcinoma in chronic viral hepatitis: Is it time to personalize it?
Coşkun Özer Demirtaş, Maurizia Brunetto
World Journal of Gastroenterology (2021) Vol. 27, Iss. 33, pp. 5536-5554
Open Access | Times Cited: 16
PAGE-B and REACH-B Predicts the Risk of Developing Hepatocellular Carcinoma in Chronic Hepatitis B Patients from Northeast, Brazil
Alessandra Porto de Macedo Costa, Marcos Antônio Custódio Neto da Silva, Rogério Soares Castro, et al.
Viruses (2022) Vol. 14, Iss. 4, pp. 732-732
Open Access | Times Cited: 12
Reduced Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Receiving Long-Term Besifovir Therapy
Hyung Joon Yim, Seong Hee Kang, Young Kul Jung, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 887-887
Open Access | Times Cited: 2
Prediction model of hepatitis B virus-related hepatocellular carcinoma in patients receiving antiviral therapy
Beom Kyung Kim, Sang Hoon Ahn
Journal of the Formosan Medical Association (2023) Vol. 122, Iss. 12, pp. 1238-1246
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top